06/03/2026
Can a medication originally developed for diabetes and weight loss help reduce alcohol cravings?
New 2026 research suggests that GLP-1 medications like semaglutide (Ozempic® and Wegovy®) may help people with alcohol use disorder drink less, experience fewer cravings, and reduce heavy drinking days. While these medications aren't FDA-approved for AUD, the science is creating new possibilities for recovery.
Learn what the latest studies reveal, who may benefit, and why medication works best when combined with therapy and structured support.
https://wishrehab.com/blog/can-glp-1s-treat-alcohol-use-disorder-2026-research